Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer.

被引:0
|
作者
Kadono, Toru
Iwasa, Satoru
Hirano, Hidekazu
Shoji, Hirokazu
Okita, Natsuko Okita
Takashima, Atsuo
Kato, Ken
机构
[1] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
322
引用
收藏
页码:322 / 322
页数:1
相关论文
共 50 条
  • [41] Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan
    Sawaki, Masataka
    Muramatsu, Yasuaki
    Togo, Kanae
    Laurent, Thomas
    Iwata, Hiroji
    FUTURE ONCOLOGY, 2022, 18 (17) : 2101 - 2111
  • [42] Real-world advanced gastric cancer treatment patterns in Western and Asian countries
    Rha, S. Y.
    Calvo, E.
    Contente, M.
    Rider, A.
    Maglinte, G.
    Clarke, B.
    Muro, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)RWD on T-DXd for gastric cancer in Japan
    Hisato Kawakami
    Koki Nakanishi
    Akitaka Makiyama
    Hirotaka Konishi
    Satoshi Morita
    Yukiya Narita
    Naotoshi Sugimoto
    Keiko Minashi
    Motohiro Imano
    Rin Inamoto
    Yasuhiro Kodera
    Hiroki Kume
    Keita Yamaguchi
    Wataru Hashimoto
    Kei Muro
    Gastric Cancer, 2025, 28 (1) : 51 - 61
  • [44] Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto., Naoya
    JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [45] Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan
    Kishimoto, Megumi
    Komine, Mayumi
    Kamiya, Koji
    Sugai, Junichi
    Mieno, Makiko
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2020, 47 (01): : 33 - 40
  • [46] Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis
    Owonikoko, Taofeek K.
    Ragin, Camille
    Chen, Zhengjia
    Kim, Sungjin
    Behera, Madhusmita
    Brandes, Johann C.
    Saba, Nabil F.
    Pentz, Rebecca
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    ONCOLOGIST, 2013, 18 (05): : 600 - 610
  • [47] Effectiveness and safety of anlotinib in patients with advanced gynecological cancer: A multi-center real-world study
    Shen, Yang
    Ding, Bo
    Hong, Xinyi
    Qiu, Shanhu
    Chen, Bingwei
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S160 - S160
  • [48] Real world experience of docetaxel in elderly patients with advanced prostate cancer.
    Fu, Simon Yuen Fai
    Barlow, Paula
    Jacobs, Carmel Maree
    Hanning, Fritha J.
    Fong, Peter C. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Gastric cancer. Treatment of advanced disease and new drugs
    Caponigro, F
    Facchini, G
    Nasti, G
    Iaffaioli, RV
    FRONTIERS IN BIOSCIENCE, 2005, 10 : 3122 - 3126
  • [50] Real-world outcomes in patients with advanced or metastatic gastric adenocarcinoma in the United States
    Beachler, D.
    Lamy, F.
    Kolitsopoulos, F.
    Dinh, J.
    Papazian, A.
    Jamal-Allial, A.
    Verpillat, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S103 - S103